Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Genetic testing"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Article
Clinical Study
Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population
Heewon Choi, Kyoung Jin Kim, Namki Hong, Saeam Shin, Jong-Rak Choi, Sang Wook Kang, Seung Tae Lee, Yumie Rhee
Endocrinol Metab. 2020;35(4):858-872.   Published online December 23, 2020
DOI: https://doi.org/10.3803/EnM.2020.683
  • 4,608 View
  • 186 Download
  • 8 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Pheochromocytoma and paragangliomas (PPGL) are hereditary in approximately 30% to 40% cases. With the advancement of genetic analysis techniques, including next-generation sequencing (NGS), there were attempts to classify PPGL into molecular clusters. With NGS being applied to clinical settings recently, we aimed to review the results of genetic analysis, including NGS, and investigate the association with clinical characteristics in Korean PPGL patients.
Methods
We reviewed the medical records of PPGL patients who visited Severance hospital from 2006 to 2019. We documented the clinical phenotype of those who underwent targeted NGS or had known germline mutations of related genes.
Results
Among 57 PPGL patients, we found 28 pathogenic germline mutations of susceptibility genes. Before the targeted NGS was implemented, only obvious syndromic feature lead to the Sanger sequencing for the specific genes. Therefore, for the exact prevalence, only patients after the year 2017, when targeted NGS was added, were included (n=43). The positive germline mutations were found in 14 patients; thus, the incidence rate is 32.6%. Patients with germline mutations had a higher likelihood of family history. There were significant differences in the type of PPGLs, percentage of family history, metastasis rate, presence of other tumors, and biochemical profile among three molecular clusters: pseudohypoxic tricarboxylic acid cycle-related, pseudohypoxic von Hippel-Lindau (VHL)/endothelial PAS domain-containing protein 1-related, and kinase-signaling group. Germline mutations were identified in seven PPGL-related genes (SDHB, RET, VHL, NF1, MAX, SDHA, and SDHD).
Conclusion
We report the expected prevalence of germline mutations in Korean PPGL patients. NGS is a useful and accessible tool for genetic analysis in patients with PPGLs, and further research on molecular classification is needed for precise management.

Citations

Citations to this article as recorded by  
  • Patient Sex and Origin Influence Distribution of Driver Genes and Clinical Presentation of Paraganglioma
    Susan Richter, Nicole Bechmann
    Journal of the Endocrine Society.2024;[Epub]     CrossRef
  • Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients
    Chong Li, Jingyi Li, Chao Han, Ting Wang, Lixia Zhang, Zhifang Wang, Tingting Wang, Lijun Xu, Guangzhao Qi, Guijun Qin, Xialian Li, Lili Zheng
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Genetic Study in Pheochromocytoma: Is It Possible to Stratify the Risk of Hereditary Pheochromocytoma?
    Marta Araujo-Castro, César Mínguez Ojeda, Iñigo García Sanz, Maria Calatayud, Felicia Hanzu, Mireia Mora, Almudena Vicente, Concepción Blanco Carrera, Paz de Miguel Novoa, María del Carmen López García, Cristina Lamas, Laura Manjón-Miguélez, María del Cas
    Neuroendocrinology.2023; 113(6): 657.     CrossRef
  • The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
    Petra Hudler, Mojca Urbancic
    Genes.2022; 13(2): 362.     CrossRef
  • Bilateral Pheochromocytoma with Germline MAX Variant without Family History
    Shinnosuke Hata, Mai Asano, Hiroyuki Tominaga, Masahide Hamaguchi, Fumiya Hongo, Takeshi Usui, Eiichi Konishi, Michiaki Fukui
    Clinics and Practice.2022; 12(3): 299.     CrossRef
  • Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
    Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
    Endocrinology and Metabolism.2021; 36(2): 322.     CrossRef
  • Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
    Masato Yonamine, Koichiro Wasano, Yuichi Aita, Takehito Sugasawa, Katsutoshi Takahashi, Yasushi Kawakami, Hitoshi Shimano, Hiroyuki Nishiyama, Hisato Hara, Mitsuhide Naruse, Takahiro Okamoto, Tadashi Matsuda, Shinji Kosugi, Kazuhiko Horiguchi, Akiyo Tanab
    Cancers.2021; 13(16): 4014.     CrossRef
  • Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
    Yinjie Gao, Chao Ling, Xiaosen Ma, Huiping Wang, Yunying Cui, Min Nie, Anli Tong, Dario De Biase
    International Journal of Endocrinology.2021; 2021: 1.     CrossRef
Close layer
Review Article
Thyroid
Genetic Polymorphism Predisposing to Differentiated Thyroid Cancer: A Review of Major Findings of the Genome-Wide Association Studies
Vladimir A. Saenko, Tatiana I. Rogounovitch
Endocrinol Metab. 2018;33(2):164-174.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.164
  • 6,246 View
  • 86 Download
  • 28 Web of Science
  • 26 Crossref
AbstractAbstract PDFPubReader   ePub   

Thyroid cancer has one of the highest hereditary component among human malignancies as seen in medical epidemiology investigations, suggesting the potential meaningfulness of genetic studies. Here we review researches into genetic variations that influence the chance of developing non-familial differentiated thyroid cancer (DTC), focusing on the major findings of the genome-wide association studies (GWASs) of common single-nucleotide polymorphisms (SNPs). To date, eight GWAS have been performed, and the association of a number of SNPs have been reproduced in dozens of replication investigations across different ethnicities, including Korea and Japan. Despite the cumulative effect of the strongest SNPs demonstrates gradual increase in the risk for cancer and their association signals are statistically quite significant, the overall prediction ability for DTC appears to be very limited. Thus, genotyping of common SNPs only would be insufficient for evidence-based counseling in clinical setting at present. Further studies to include less significant and rare SNPs, non-SNP genetic information, gene-gene interactions, ethnicity, non-genetic and environmental factors, and development of more advanced computational algorithms are warranted to approach to personalized disease risk prediction and prognostication.

Citations

Citations to this article as recorded by  
  • Radiation-Related Thyroid Cancer
    Vladimir Saenko, Norisato Mitsutake
    Endocrine Reviews.2024; 45(1): 1.     CrossRef
  • Gene variants polymorphisms and uterine leiomyoma: an updated review
    Sonal Upadhyay, Pawan K. Dubey
    Frontiers in Genetics.2024;[Epub]     CrossRef
  • Disease-associated non-coding variants alter NKX2-5 DNA-binding affinity
    Edwin G. Peña-Martínez, Alejandro Rivera-Madera, Diego A. Pomales-Matos, Leandro Sanabria-Alberto, Brittany M. Rosario-Cañuelas, Jessica M. Rodríguez-Ríos, Emanuel A. Carrasquillo-Dones, José A. Rodríguez-Martínez
    Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.2023; 1866(1): 194906.     CrossRef
  • The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update
    Robert Aurelian Tiucă, Oana Mirela Tiucă, Ionela Maria Pașcanu
    Biomedicines.2023; 11(4): 1075.     CrossRef
  • Genetic susceptibility to hereditary non-medullary thyroid cancer
    Tina Kamani, Parsa Charkhchi, Afshan Zahedi, Mohammad R. Akbari
    Hereditary Cancer in Clinical Practice.2022;[Epub]     CrossRef
  • Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach
    Giulia Brigante, Clara Lazzaretti, Elia Paradiso, Federico Nuzzo, Martina Sitti, Frank Tüttelmann, Gabriele Moretti, Roberto Silvestri, Federica Gemignani, Asta Försti, Kari Hemminki, Rossella Elisei, Cristina Romei, Eric Adriano Zizzi, Marco Agostino Der
    European Thyroid Journal.2022;[Epub]     CrossRef
  • Study of single nucleotide polymorphism of vascular endothelium factor in patients with differentiated thyroid cancer
    Mohamad Mohsen Motawea, Maysaa El Sayed Zaki, Maha Saif, Asmaa Osama BS Osman, Aml Mohamed Nada
    Clinical Diabetes and Endocrinology.2022;[Epub]     CrossRef
  • The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations
    Zhanna Mussazhanova, Tatiana I. Rogounovitch, Vladimir A. Saenko, Ainur Krykpayeva, Maira Espenbetova, Bauyrzhan Azizov, Hisayoshi Kondo, Katsuya Matsuda, Zhanna Kalmatayeva, Raushan Issayeva, Zhanar Yeleubayeva, Madina Madiyeva, Aray Mukanova, Marat Sand
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma
    Danuta Gąsior-Perczak, Artur Kowalik, Krzysztof Gruszczyński, Agnieszka Walczyk, Monika Siołek, Iwona Pałyga, Sławomir Trepka, Estera Mikina, Tomasz Trybek, Janusz Kopczyński, Agnieszka Suligowska, Rafał Ślusarczyk, Agnieszka Gonet, Jarosław Jaskulski, Pa
    Cancers.2021; 13(3): 470.     CrossRef
  • Carcinoma diferenciado de tiroides familiar: más allá de las formas sindrómicas
    Aida Orois, Mireia Mora, Irene Halperin, Josep Oriola
    Endocrinología, Diabetes y Nutrición.2021; 68(4): 260.     CrossRef
  • Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma
    Om Kulkarni, Pierre-Emmanuel Sugier, Julie Guibon, Anne Boland-Augé, Christine Lonjou, Delphine Bacq-Daian, Robert Olaso, Carole Rubino, Vincent Souchard, Frédérique Rachedi, Juan Jesus Lence-Anta, Rosa Maria Ortiz, Constance Xhaard, Pierre Laurent-Puig,
    Scientific Reports.2021;[Epub]     CrossRef
  • Familial non medullary thyroid carcinoma: Beyond the syndromic forms
    Aida Orois, Mireia Mora, Irene Halperin, Josep Oriola
    Endocrinología, Diabetes y Nutrición (English ed.).2021; 68(4): 260.     CrossRef
  • Discrimination between 34 of 36 Possible Combinations of Three C>T SNP Genotypes in the MGMT Promoter by High Resolution Melting Analysis Coupled with Pyrosequencing Using A Single Primer Set
    Katja Zappe, Christine Pirker, Heidi Miedl, Martin Schreiber, Petra Heffeter, Georg Pfeiler, Stefan Hacker, Werner Haslik, Sabine Spiegl-Kreinecker, Margit Cichna-Markl
    International Journal of Molecular Sciences.2021; 22(22): 12527.     CrossRef
  • Emerging Biomarkers in Thyroid Practice and Research
    Shipra Agarwal, Andrey Bychkov, Chan-Kwon Jung
    Cancers.2021; 14(1): 204.     CrossRef
  • The effects of the genetic polymorphisms of antioxidant enzymes on susceptibility to papillary thyroid carcinoma
    Saeedeh Salimi, Mahdiyeh Harati‐Sadegh, Moein Eskandari, Zahra Heidari
    IUBMB Life.2020; 72(5): 1045.     CrossRef
  • Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study
    Huan-Tang Lin, Fu-Chao Liu, Shu-Fu Lin, Chang-Fu Kuo, Yu-Ying Chen, Huang-Ping Yu
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(7): e2521.     CrossRef
  • Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
    Kinga Hińcza, Artur Kowalik, Iwona Pałyga, Agnieszka Walczyk, Danuta Gąsior-Perczak, Estera Mikina, Tomasz Trybek, Monika Szymonek, Klaudia Gadawska-Juszczyk, Klaudia Zajkowska, Agnieszka Suligowska, Artur Kuchareczko, Karol Krawczyk, Janusz Kopczyński, M
    Cancers.2020; 12(2): 423.     CrossRef
  • The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features
    Zahra Heidari, Mahdiyeh Harati‐Sadegh, Abtin Arian, Rostam Maruei‐Milan, Saeedeh Salimi
    IUBMB Life.2020; 72(5): 922.     CrossRef
  • Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also S
    Valentina Drozd, Rita Schneider, Tamara Platonova, Galina Panasiuk, Tatjana Leonova, Nataliya Oculevich, Irina Shimanskaja, Irina Vershenya, Tatjana Dedovich, Tatjana Mitjukova, Inge Grelle, Johannes Biko, Christoph Reiners
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer
    Fabíola Yukiko Miasaki, Cesar Seigi Fuziwara, Gisah Amaral de Carvalho, Edna Teruko Kimura
    Genes.2020; 11(11): 1364.     CrossRef
  • Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
    Kinga Hińcza, Artur Kowalik, Aldona Kowalska
    Genes.2019; 10(7): 482.     CrossRef
  • Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes
    Santos, Gomes, Bastos, Gil, Azevedo, Ferreira, Limbert, Silva, Rueff
    Genes.2019; 10(8): 586.     CrossRef
  • Effect of the thymine‐DNA glycosylase rs4135050 variant on Saudi smoker population
    Mikhlid Almutairi, Abdullah Mohammad Alhadeq, Rafa Almeer, Mohammed Almutairi, Mohammed Alzahrani, Abdelhabib Semlali
    Molecular Genetics & Genomic Medicine.2019;[Epub]     CrossRef
  • Association of Vitamin D Pathway Genetic Variation and Thyroid Cancer
    Isabel S. Carvalho, Catarina I. Gonçalves, Joana T. Almeida, Teresa Azevedo, Teresa Martins, Fernando J. Rodrigues, Manuel C. Lemos
    Genes.2019; 10(8): 572.     CrossRef
  • Association of radiation risk in the second and third generations with polymorphisms in the genes CYP1A1, CYP2E1, GSTP1 and changes in the thyroid
    Meruyert Massabayeva, Nailya Chaizhunusova, Nurlan Aukenov, Tolkyn Bulegenov, Bakytbek Apsalikov, Aigerim Shapihanova, Yersin Zhunussov
    Molecular Medicine.2019;[Epub]     CrossRef
  • BRAF‐positive multifocal and unifocal papillary thyroid cancer show different messenger RNA expressions
    Kyoungjune Pak, Sunghwan Suh, Tae Sik Goh, Seong‐Jang Kim, Sae‐Ock Oh, Ju Won Seok, In Joo Kim, Yun Hak Kim
    Clinical Endocrinology.2019; 90(4): 601.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism